What is Medgluv?
Medgluv Inc operates as a critical node in the healthcare logistics ecosystem, specializing in the procurement and distribution of high-quality medical gloves and personal protective equipment (PPE). By maintaining a diverse portfolio that includes both sterile and non-sterile exam and surgical gloves, the company addresses the essential needs of clinical environments. As a minority-owned enterprise, Medgluv distinguishes itself through a commitment to rigorous quality compliance and cost-effective sourcing strategies. Its market position is defined by a reliable supply chain network that bridges the gap between global manufacturing hubs and frontline healthcare providers, ensuring that caregivers have consistent access to vital safety equipment.
How much funding has Medgluv raised?
Medgluv has raised a total of $3.8M across 1 funding round:
Debt
$3.8M
Debt (2025): $3.8M with participation from Amerant
Key Investors in Medgluv
Amerant
Amerant is a prominent financial institution providing comprehensive banking and commercial lending solutions to support the growth of mid-to-large scale enterprises.
What's next for Medgluv?
With the recent influx of capital, Medgluv is positioned to optimize its inventory management systems and expand its footprint in the competitive PPE market. The strategic deployment of these funds will likely focus on strengthening procurement resilience and enhancing distribution efficiency to meet the evolving demands of the healthcare industry. As the company transitions into this next phase of growth, the focus remains on maintaining high-standard compliance while scaling operations to support larger institutional clients. This financial milestone provides the necessary runway to solidify its reputation as a dependable partner in medical supply chain management, potentially allowing for further diversification of its product offerings and deeper penetration into regional healthcare networks.
See full Medgluv company page
